background image
ARRAY BIOPHARMA, INC.
Notes to the Financial Statements (Continued)
For the Fiscal Years Ended June 30, 2012, 2011 and 2010
NOTE 15 SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED See accompanying
accountants' report)
The tables below summarize the Company's unaudited quarterly operating results for the fiscal years
ended June 30, 2012 and 2011 (dollars in thousands, except per share data):
First
Second
Third
Fourth
Fiscal Year Ended June 30, 2012
Quarter
Quarter
Quarter
Quarter
Revenue
$ 22,131
$ 23,228
$ 19,113
$ 20,663
Research and development for proprietary
drug discovery
$ 12,598
$ 13,150
$ 16,094
$ 14,877
Total operating expenses
$ 22,762
$ 23,198
$ 24,611
$ 25,611
Net loss
$
(3,580)
$
(3,803)
$
(8,168)
$
(8,030)
Weighted average shares outstanding
basic and diluted
57,025
60,004
74,817
90,897
Net loss per share basic and diluted
$
(0.06)
$
(0.06)
$
(0.11)
$
(0.09)
First
Second
Third
Fourth
Fiscal Year Ended June 30, 2011
Quarter
Quarter
Quarter
Quarter
Revenue
$ 18,513
$ 16,501
$ 17,841
$ 19,046
Research and development for proprietary
drug discovery
$ 13,855
$ 14,482
$ 15,883
$ 19,278
Total operating expenses
$ 25,404
$ 25,769
$ 26,295
$ 31,207
Net loss
$ (10,630)
$ (12,442)
$ (11,502)
$ (21,752)
Weighted average shares outstanding
basic and diluted
53,415
55,285
56,129
56,991
Net loss per share basic and diluted
$
(0.20)
$
(0.23)
$
(0.20)
$
(0.38)
The Net Loss per Share amounts above may not sum to the annual amounts presented in the Company's
accompanying Statements of Operations and Comprehensive Loss due to rounding.
NOTE 16 SUBSEQUENT EVENT
The Company has evaluated subsequent events after the balance sheet date of June 30, 2012 and up to
the date the Company filed this Annual Report.
F-48
EXHIBIT INDEX
Exhibit Footnote
No.
Ref.
Description
3.1
(1)
Amended and Restated Certificate of Incorporation of Array BioPharma Inc.
3.2
(14)
Amendment to Amended and Restated Certificate of Incorporation of Array
BioPharma Inc.
3.3
(17)
Bylaws of Array BioPharma Inc., as amended and restated on October 30, 2008
3.4
(2)
Certificate of Designation of the Series A Junior Participating Preferred Stock
3.5
(27)
Certificate of Designation of the Series B Convertible Preferred Stock
4.1
(1)
Specimen certificate representing the common stock
4.2
(18)
Registration Rights Agreement dated May 15, 2009 between the Registrant and
Deerfield Private Design Fund, L.P. and Deerfield Private Design
International, L.P.
4.3
(25)
Form of Warrant to purchase shares of the registrant's Common Stock issued to
Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P.,
Deerfield Partners, L.P., Deerfield International, Limited
4.4
(27)
Form of Amendment No. 1 to Warrant to purchase shares of the registrant's
Common Stock issued to Deerfield Private Design Fund, L.P., Deerfield Private
Design International, L.P., Deerfield Partners, L.P., Deerfield International,
Limited
10.1
(1)
Preferred and Common Stock Purchase Agreement between Registrant and the
parties whose signatures appear on the signature pages thereto dated May 18,
1998
10.2
(1)
Amendment to Preferred and Common Stock Purchase Agreement dated
August 7, 1998
10.3
(1)
Series B Preferred Stock Purchase Agreement between Registrant and the
parties whose signatures appear on the signature pages thereto dated
November 16, 1999
10.4
(1)
Series C Preferred Stock Purchase Agreement between Registrant and the
parties whose signatures appear on the signature pages thereto dated August 31,
2000
10.5
(1)
Amended and Restated Investor Rights Agreement between Registrant and the
parties whose signatures appear on the signature pages thereto dated
November 16, 1999
10.6
(1)
Amendment No. 1 to Amended and Restated Investor Rights Agreement between
Registrant and the parties whose signatures appear on the signature pages
thereto dated August 31, 2000
10.7
(1)
1998 Stock Option Plan effective July 1, 1998, as amended*
10.8
(6)
Amended and Restated Array BioPharma Inc. Stock Option and Incentive Plan, as
amended*
10.9
+
Amendment to Amended and Restated Array BioPharma Inc. Stock Option and
Incentive Plan, as amended*
10.10
(13)
Form of Incentive Stock Option Agreement, as amended*